企業プロフィール
Carisma Therapeutics, Inc. 株価・ニュース・カタリスト
- ティッカー:
- CARM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
0.00 USD (-47.83%)
終値
最終更新: 2026年8月21日
—
時価総額
株価変動の要因
As of Aug 21, 2026, CARM closed down 47.8% at $0.0012. No new same-company headline was identified in the current news window.
企業概要
事業概要
Carisma Therapeutics is a cell-therapy company focused on engineered macrophages and cancer immunotherapy. Its story centers on using a novel immune-cell approach to attack tumors.
所在地とセクター分類
Carisma is headquartered in the United States and listed on NASDAQ. It sits in cell therapy and oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, manufacturing feasibility, and capital support while it advances a narrow pipeline. Investors watch early data and platform differentiation.
バイオ業界での位置付け
Carisma occupies a specialized macrophage-cell-therapy niche within biotech. It is catalyst-sensitive because the platform still needs to prove itself clinically.
今後のカタリスト
- Carisma’s catalysts are macrophage-engineering programs and any strategic or clinical update that clarifies the company’s next path. The company still needs stronger human proof.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。